2,669 Shares in Aflac Incorporated (NYSE:AFL) Purchased by Hirtle Callaghan & Co LLC

Hirtle Callaghan & Co LLC acquired a new stake in Aflac Incorporated (NYSE:AFL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,669 shares of the financial services provider's stock, valued at approximately $276,000.

A number of other large investors have also made changes to their positions in the stock. Whipplewood Advisors LLC purchased a new stake in shares of Aflac during the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new position in Aflac in the 4th quarter valued at $34,000. Raelipskie Partnership purchased a new position in shares of Aflac during the 3rd quarter worth $38,000. Curio Wealth LLC acquired a new stake in shares of Aflac during the fourth quarter worth $36,000. Finally, OFI Invest Asset Management purchased a new stake in shares of Aflac in the fourth quarter valued at $38,000. Institutional investors and hedge funds own 67.44% of the company's stock.

Insider Activity

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares of the company's stock, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the sale, the director now owns 49,962 shares in the company, valued at $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.90% of the company's stock.

Remove Ads

Aflac Stock Down 1.0 %

NYSE AFL traded down $1.07 on Friday, reaching $109.71. The company had a trading volume of 1,876,401 shares, compared to its average volume of 2,120,892. The firm has a market capitalization of $59.97 billion, a PE ratio of 11.43, a P/E/G ratio of 3.24 and a beta of 0.93. The firm has a 50-day moving average of $106.49 and a 200-day moving average of $107.66. Aflac Incorporated has a 1 year low of $79.31 and a 1 year high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.

Aflac (NYSE:AFL - Get Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, equities research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have issued reports on the company. JPMorgan Chase & Co. raised their price target on Aflac from $90.00 to $94.00 and gave the stock a "neutral" rating in a research note on Tuesday, January 7th. Morgan Stanley increased their price target on shares of Aflac from $98.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Friday, February 28th. Barclays lowered their price objective on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a research note on Friday, February 7th. BMO Capital Markets assumed coverage on Aflac in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 target price on the stock. Finally, StockNews.com raised Aflac from a "sell" rating to a "hold" rating in a research report on Friday, February 14th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.